Literature DB >> 25291684

Synthetic peptides: a next generation of vaccines?

M W Steward1, C R Howard.   

Abstract

Of the strategies being considered in the search for new kinds of vaccine, one of the most powerful is the use of synthetic peptides. Here, Michael Steward and Colin Howard discuss recent insights into the nature of antigenicity which influence the use of such peptides, and review the value of peptide immunogens in a variety of diseases.
Copyright © 1987. Published by Elsevier B.V.

Entities:  

Year:  1987        PMID： 25291684     DOI： 10.1016/0167-5699(87)90239-8

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


  4 in total

1.  Conserved MHC class I-presented dengue virus epitopes identified by immunoproteomics analysis are targets for cross-serotype reactive T-cell response.

Authors:  James S Testa; Vivekananda Shetty; Gomathinayagam Sinnathamby; Zacharie Nickens; Julie Hafner; Shivali Kamal; Xianchao Zhang; Marti Jett; Ramila Philip
Journal:  J Infect Dis       Date:  2012-01-13       Impact factor: 5.226

2.  Use of synthetic peptides to identify surface-exposed, linear B-cell epitopes within outer membrane protein F of Pseudomonas aeruginosa.

Authors:  H E Gilleland; E E Hughes; L B Gilleland; J M Matthews-Greer; J Staczek
Journal:  Curr Microbiol       Date:  1995-11       Impact factor: 2.188

3.  Immune responses to wild and vaccine rubella viruses after rubella vaccination.

Authors:  M G Cusi; R Metelli; P E Valensin
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

4.  A 20-kilodalton N-terminal fragment of the D15 protein contains a protective epitope(s) against Haemophilus influenzae type a and type b.

Authors:  Y p Yang; W R Thomas; P Chong; S M Loosmore; M H Klein
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.